A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.
about
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@en
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@nl
type
label
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@en
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@nl
prefLabel
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@en
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@nl
P2093
P2860
P356
P1476
A Randomized, Double-Blind, Pl ...... own Syndrome without Dementia.
@en
P2093
Brian G Skotko
Casey Evans
ELND005-DS Study Group
Eric Doran
Gabriela Muranevici
Ira T Lott
Margaret Pulsifer
Mary Ellen McDonough
Michael S Rafii
Patrick Kesslak
P2860
P304
P356
10.3233/JAD-160965
P577
2017-04-25T00:00:00Z